E O’Brien

4.8k citations
74 papers · 3.5k · 1 hit paper · h-index 28

Impact in

Papers in

E O’Brien

72 papers receiving 3.3k citations

E O’Brien's Hit Papers

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer 2004 · 1.3k citations
1.3k0+7+14Years since publication4008001.2k

Peers

E O’Brien
Comparison fields: 5 of 148
  • Biomaterials 610
  • Cardiology and Cardiovascular Medicine 848
  • Oncology 589
  • Cancer Research 247
  • Pulmonary and Respiratory Medicine 515
Replace Omaida C. Velázquez with:
Omaida C. Velázquez United States
Howard Leong‐Poi Canada
László Rosivall Hungary
Wei‐Ming Li Taiwan
Juying Qian China
Haim Danenberg Israel
Mark L. Barr United States
Kentaro Shimokado Japan
Robert J. Boucek United States
Katherine Gallagher United States
E O’Brien relative to Omaida C. Velázquez United States Omaida C. Velázquez's profile →
Citations per field
00.5×1.7×
Omaida C. Velázquez · 1×
Citations per year

Countries citing papers authored by E O’Brien

Since Specialization
Citations

This map shows the geographic impact of E O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E O’Brien more than expected).

Fields of papers citing papers by E O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E O’Brien. The network helps show where E O’Brien may publish in the future.

Co-authors

The 25 scholars most cited alongside E O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E O’Brien Line = papers co-authored together E O’Brien links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Hit paper breakdown →
20041326
2 2000350
3 1992148
4 2004111
5 1993105
6 200583
7 200181
8 200879
9
Consensus document on non-invasive ambulatory blood pressure monitoring
199074
10 198267
11 199867
12 201154
13 198353
14 201451
15
Blood pressure measurement : recommendations of the British Hypertension Society
199751
16 202249
17 201543
18 200643
19
Social Media Spread During Covid-19: The Pros and Cons of Likes and Shares.
202043
20 198336

About E O’Brien

E O’Brien is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Surgery, having authored 74 papers that have together received 3.5k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (15 papers), Lung Cancer Treatments and Mutations (7 papers), Heart Rate Variability and Autonomic Control (6 papers), Cardiovascular Health and Disease Prevention (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Hemodynamic Monitoring and Therapy (4 papers), Lung Cancer Research Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Biomaterials (610 citations), Cardiology and Cardiovascular Medicine (848 citations), Oncology (589 citations), Cancer Research (247 citations) and Pulmonary and Respiratory Medicine (515 citations). E O’Brien has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Piotr Tomczak, D G Kieback, Eva‐Maria Grischke, L. Mellars, Craig Tendler, R. Rosso, Stephen P. Ackland, Moshe Inbar, Armando Santoro and Leila Alland. Their work appears in journals such as Annals of Oncology, American Journal of Hypertension, British Journal of Cancer, Lung Cancer and Thorax.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact